Get started
Author

Fabrizio Tabbò

Observed names: F Tabbo', F Tabbò, F. Tabbo, F. Tabbo', F. Tabbò, Fabrizio TABBÒ, Fabrizio Tabbo, Fabrizio Tabbo', Fabrizio Tabbo’, Fabrizio Tabbó, Tabbo, F, Tabbo’, Fabrizio, Tabbò, Fabrizio
Observed institutions: Northwestern University, BC Cancer Agency, NewYork–Presbyterian Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Cornell University, University of Chicago, Institute for Research in Immunology and Cancer, IBM Research - Brazil, Italian institute for Genomic Medicine, Azienda Sanitaria Locale CN2, Cancer Hospital of Chinese Academy of Medical Sciences, Ospedale San Luigi Gonzaga, Union Hospital, Weill Cornell Medicine, Ospedale Michele e Pietro Ferrero - Verduno, Weill Cornell Medical Center, University of Turin, Université de Montréal
ORCID: 0000-0001-8525-2992
Observed ORCID: 0000-0001-8525-2992
OpenAlex ID: A5050303493
Genetics of Follicular Lymphoma Transformation
2014 · Laura Pasqualucci, Hossein Khiabanian, et al. · Cell Reports · 590
Convergent Mutations and Kinase Fusions Lead to Oncogenic STAT3 Activation in Anaplastic Large Cell Lymphoma
2015 · Ramona Crescenzo, Francesco Abate, et al. · Cancer Cell · 451
PDF
The coding genome of splenic marginal zone lymphoma: activation of NOTCH2 and other pathways regulating marginal zone development
2012 · Davide Rossi, Vladimir Trifonov, et al. · The Journal of Experimental Medicine · 394
PDF
Clinical and Biological Subtypes of B-cell Lymphoma Revealed by Microenvironmental Signatures
2021 · Nikita Kotlov, Alexander Bagaev, et al. · Cancer Discovery · 289
Mechanism-Based Epigenetic Chemosensitization Therapy of Diffuse Large B-Cell Lymphoma
2013 · Thomas Clozel, ShaoNing Yang, et al. · Cancer Discovery · 229
CTLA4 blockade abrogates KEAP1/STK11-related resistance to PD-(L)1 inhibitors
2024 · Ferdinandos Skoulidis, Haniel A. Araujo, et al. · Nature · 215
The genetics of nodal marginal zone lymphoma
2016 · Valeria Spina, Hossein Khiabanian, et al. · Blood · 182
PDF
Epigenomic evolution in diffuse large B-cell lymphomas
2015 · Heng Pan, Yanwen Jiang, et al. · Nature Communications · 131
PDF
PRDM1/BLIMP1 is commonly inactivated in anaplastic large T-cell lymphoma
2013 · Michela Boi, Andrea Rinaldi, et al. · Blood · 119
PDF
Association of STK11/LKB1 genomic alterations with lack of benefit from the addition of pembrolizumab to platinum doublet chemotherapy in non-squamous non-small cell lung cancer.
2019 · Ferdinandos Skoulidis, Kathryn Cecilia Arbour, et al. · Journal of Clinical Oncology · 104
Baseline BMI and BMI variation during first line pembrolizumab in NSCLC patients with a PD-L1 expression ≥ 50%: a multicenter study with external validation
2020 · Alessio Cortellini, Biagio Ricciuti, et al. · Journal for ImmunoTherapy of Cancer · 103
PDF
Combinatorial targeting of nuclear export and translation of RNA inhibits aggressive B-cell lymphomas
2015 · Biljana Culjkovic-Kraljacic, Tharu M. Fernando, et al. · Blood · 97
Integrin αvβ3 acting as membrane receptor for thyroid hormones mediates angiogenesis in malignant T cells
2014 · Florencia Cayrol, María Celeste Díaz Flaqué, et al. · Blood · 95
PDF
Potential Diagnostic and Prognostic Role of Microenvironment in Malignant Pleural Mesothelioma
2019 · Iris C. Salaroglio, Joanna Kopecka, et al. · Journal of Thoracic Oncology · 74
PDF
HDAC7 promotes NSCLC proliferation and metastasis via stabilization by deubiquitinase USP10 and activation of β-catenin-FGF18 pathway
2022 · Kai Guo, Zhiqiang Ma, et al. · Journal of Experimental & Clinical Cancer Research · 68
PDF
Predicting immunotherapy outcomes under therapy in patients with advanced NSCLC using dNLR and its early dynamics
2021 · Laura Mezquita, Isabel Preeshagul, et al. · European Journal of Cancer · 60
Pulmonary Adenocarcinoma With Enteric Differentiation: Immunohistochemistry and Molecular Morphology
2016 · Alessia Nottegar, Fabrizio Tabbò, et al. · Applied immunohistochemistry & molecular morphology · 56
ALK/EML4 Fusion Gene May Be Found in Pure Squamous Carcinoma of the Lung
2014 · Anna Caliò, Alessia Nottegar, et al. · Journal of Thoracic Oncology · 55
PDF
RET-MAP: An International Multicenter Study on Clinicobiologic Features and Treatment Response in Patients With Lung Cancer Harboring a RET Fusion
2023 · Mihaela Aldea, Arianna Marinello, et al. · Journal of Thoracic Oncology · 54
PDF
Wnt/IL‐1β/IL‐8 autocrine circuitries control chemoresistance in mesothelioma initiating cells by inducing ABCB5
2019 · Vladan Milosevic, Joanna Kopecka, et al. · International Journal of Cancer · 53
PDF
A novel patient-derived tumorgraft model with TRAF1-ALK anaplastic large-cell lymphoma translocation
2014 · F Abate, M Todaro, et al. · Leukemia · 53
Precision medicine in ALK rearranged NSCLC: A rapidly evolving scenario
2017 · Alfredo Addeo, Fabrizio Tabbò, et al. · Critical Reviews in Oncology/Hematology · 52
PDF
The Influence of Tissue Ischemia Time on RNA Integrity and Patient-Derived Xenografts (PDX) Engraftment Rate in a Non-Small Cell Lung Cancer (NSCLC) Biobank
2016 · Francesco Guerrera, Fabrizio Tabbò, et al. · PLoS ONE · 52
PDF
ALK signaling and target therapy in anaplastic large cell lymphoma
2012 · Fabrizio Tabbó · Frontiers in Oncology · 51
PDF
Extranodal extension of nodal metastases is a poor prognostic moderator in non-small cell lung cancer: a meta-analysis
2018 · Claudio Luchini, Nicola Veronese, et al. · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · 49
Works count: 275
Citation count: 4,433
H-index: 29
I10-index: 56
Year
Topic
Type